OECD Health Policy Studies Pharmaceutical Pricing Policies in a Global Market


Book Description

This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.




OECD Health Policy Studies Pharmaceutical Pricing Policies in a Global Market


Book Description

This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives, and it examines the national and transnational effects of these policies.




OECD Health Policy Studies Value for Money in Health Spending


Book Description

This publication examines current efforts to improve health care efficiency, including tools that show promise in helping health systems provide the best care for their money.







Pharmaceutical Prices in the 21st Century


Book Description

This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.




WHO guideline on country pharmaceutical pricing policies


Book Description

In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.




OECD Health Policy Studies Value for Money in Health Spending


Book Description

This publication examines current efforts to improve health care efficiency, including tools that show promise in helping health systems provide the best care for their money.




OECD Health Policy Studies Pharmaceutical Innovation and Access to Medicines


Book Description

This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.







Pharmaceutical Innovation and Access to Medicines


Book Description

This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.